(Q28538939)

English

Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial

scientific article (publication date: 2014)

In more languages

Statements

scholarly article

0 references

Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial (English)

0 references

amyotrophic lateral sclerosis

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

James B Caress

6

0 references

Vincent Meininger

1

object named as

Vincent Meininger

0 references

Pierre-François Pradat

2

object named as

Pierre-François Pradat

0 references

10

object named as

P Nigel Leigh

0 references

Merit E Cudkowicz

7

object named as

Merit Cudkowicz

0 references

Nicola Williams

19

object named as

Nicola Williams

0 references

author name string

Andrea Corse

3

0 references

Safa Al-Sarraj

4

0 references

Benjamin Rix Brooks

5

0 references

Stephen J Kolb

8

0 references

Dale Lange

9

0 references

Thomas Meyer

11

0 references

Stefano Milleri

12

0 references

Karen E Morrison

13

0 references

Richard W Orrell

14

0 references

Gary Peters

15

0 references

Jeffrey D Rothstein

16

0 references

Jeremy Shefner

17

0 references

Arseniy Lavrov

18

0 references

Phil Overend

20

0 references

Jeffrey Price

21

0 references

Stewart Bates

22

0 references

Jonathan Bullman

23

0 references

David Krull

24

0 references

Alienor Berges

25

0 references

Bams Abila

26

0 references

Guy Meno-Tetang

27

0 references

Jens Wurthner

28

0 references

language of work or name

0 references

publication date

2014

0 references

0 references

9

0 references

5

0 references

e97803

0 references

copyright license

Creative Commons Attribution 4.0 International

19 May 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Therapeutic neuroprotective agents for amyotrophic lateral sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

19 March 2017

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

19 March 2017

Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

19 March 2017

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

7 April 2017

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

29 September 2017

Controversies and priorities in amyotrophic lateral sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

29 September 2017

Multipoint incremental motor unit number estimation as an outcome measure in ALS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

29 September 2017

A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

29 September 2017

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

29 September 2017

The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

29 September 2017

Nogo and axon regeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

29 September 2017

From Charcot to SOD1: mechanisms of selective motor neuron death in ALS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

29 September 2017

Therapeutic horizons for amyotrophic lateral sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

29 September 2017

Prevalence and patterns of cognitive impairment in sporadic ALS.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0097803

21 January 2018

Functions of Nogo proteins and their receptors in the nervous system.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0097803

21 January 2018

Nogo (Reticulon 4) expression in innervated and denervated mouse skeletal muscle

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0097803

21 January 2018

Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0097803

21 January 2018

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0097803

21 January 2018

Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0097803

21 January 2018

The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0097803

21 January 2018

Increased expression of Noga-A in ALS muscle biopsies is not unique for this disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4026380

27 November 2018

Expression of Nogo-A in human muscle fibers is not specific for amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24841795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscle Nogo-A: a marker for amyotrophic lateral sclerosis or for denervation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24841795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24841795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man

1 reference

https://pubmed.ncbi.nlm.nih.gov/24841795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24841795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24841795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Motor neuron disease: the bare essentials

1 reference

https://pubmed.ncbi.nlm.nih.gov/24841795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0097803

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2014PLoSO...997803M

0 references

release_pprav3wc4vedxgi5aa6qvhnuj4

1 reference

https://api.fatcat.wiki/v0/release/pprav3wc4vedxgi5aa6qvhnuj4

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28538939&oldid=1861693818"